Electrospinning of Cyclodextrin-Oligolactide Derivatives

Electrospinning of Cyclodextrin-Oligolactide Derivatives

Electrospinning of Cyclodextrin-Oligolactide Derivatives
INQUIRY

Electrospinning is an advanced technique that has revolutionized the production of nanofibers, offering control over fiber diameter, morphology, and surface properties. The ability to manipulate these parameters enables the development of fibers with tailored functionalities for a range of applications, particularly in biomedical and environmental fields. Cyclodextrin-oligolactide derivatives (CDLA) have emerged as a novel material for electrospinning, combining the unique properties of cyclodextrins with the biodegradable nature of oligolactides.

Synthesis of Cyclodextrin-Oligolactide Derivatives (CDLA)

  • Chemical Synthesis of CDLA

In the context of electrospinning, cyclodextrin-oligolactide derivatives (CDLA) can be synthesized through the ring-opening polymerization (ROP) of L-lactic acid initiated by β-cyclodextrin [1]. This reaction typically uses 4-dimethylaminopyridine (DMAP) as a catalyst, facilitating the formation of CDLA with a high degree of purity and controlled molecular weight.

  • Electrospinning Process

By applying a high voltage to a polymer solution, a charged jet of the solution is ejected from a needle, and as the solvent evaporates, the result is the formation of fibers on a collector. The electrospinning of CDLA is a highly sensitive process where the morphology of the resulting fibers is heavily influenced by several key parameters:

  • Applied Voltage: A higher voltage results in thinner fibers, but excessive voltage may lead to fiber instability and the formation of beads.
  • Needle to Collector Distance: The distance between the needle and the collector affects the evaporation rate of the solvent and the time available for fiber formation.
  • Flow Rate: A higher flow rate may lead to thicker fibers, while a lower flow rate typically results in thinner fibers.
  • Concentration of the Cyclodextrin Solution: Too high a concentration may result in overly viscous solutions that cannot be easily electrospun, while too low a concentration may lead to weak or inconsistent fibers.

Biomedical Applications of CDLA Nanofibers

CDLA electrospun nanofibers have versatile and cutting-edge applications across various industries. Below are some key areas where these advanced materials are making significant impacts:

  • Drug Delivery Systems

The unique structure of cyclodextrins allows for the encapsulation of hydrophobic drugs, improving their solubility and bioavailability. The high surface area of the electrospun fibers facilitates efficient drug loading and controlled release, making them ideal candidates for targeted drug delivery.

  • Tissue Engineering Scaffolds

The nanofibrous structure mimics the extracellular matrix (ECM), providing a favorable environment for cell attachment, growth, and differentiation. The high surface area and tunable mechanical properties of CDLA fibers enable the creation of scaffolds that support the regeneration of various tissues, such as skin, bone, and cartilage.

  • Biodegradable Filtration Membranes

Due to their high surface area, biodegradability, and ability to adsorb molecules, electrospun CDLA nanofibers have potential as biodegradable filtration membranes. These membranes can be used for environmental applications, such as water purification and air filtration. The fibers can trap pollutants, bacteria, or viruses, making them effective in removing contaminants from water or air. As the fibers degrade over time, they do not contribute to long-term environmental pollution, making them a sustainable alternative to traditional filtration materials.

CDLA nanofibers offer a robust platform for creating biocompatible, biodegradable, and high-performance materials, paving the way for next-generation applications in medical, environmental, and industrial sectors. For more products and services, please feel free to contact us.

Reference

  1. Opalkova Siskova A, Sacarescu L, Opalek A, et al. Electrospinning of Cyclodextrin-Oligolactide Derivatives. Biomolecules. 2023 Jan 19;13(2):203.

It should be noted that our our products and services are for research use only, not for clinical use.